Definium Therapeutics (DFTX) Stock
Definium Therapeutics (DFTX) closed at $29.38 on Nov 17, 2026; its Tenet Score is 50 of 100 against 340 Healthcare peers.
35 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $29.38
- Nov 17, 2026
- Market cap
- $4.1B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 10.46 – 49.70
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 50/100
- Mixed · 340 Healthcare peers
Industry: Drugs
Definium Therapeutics Inc. scores 50/100. Mixed. Strongest on financial health, quality is the soft spot versus 340 Healthcare peers. Insufficient inputs: Tenet 50 is built from 3 of 4 pillars, from 35% of its inputs. The pillars showing a dash had no data.
Tenet Score · vs sector
n=340Factor grades
Growth omitted — no data yet.
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Drawdown Context
- ✕ Reversal Evidence
- ✕ Not-a-Value-Trap Gate
13F flows & insider trades land here.
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of ge…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Edgewise Therapeutics IncEWTX | 69 | $4.8B |
| Cogent Biosciences IncCOGT | 33 | $4.8B |
| Travere Therapeutics IncTVTX | 43 | $4.8B |
| Ionis Pharmaceuticals IncIONS | 27 | $4.7B |
| CRISPR Therapeutics AGCRSP | 64 | $3.9B |
| Tarsus Pharmaceuticals IncTARS | 34 | $3.9B |
| Xenon Pharmaceuticals IncXENE | 44 | $3.9B |
| Relay Therapeutics IncRLAY | 43 | $3.8B |
| Organon & Co.OGN | 45 | $3.7B |
| Amylyx Pharmaceuticals IncAMLX | 56 | $3.6B |
Common questions
What sector and industry is Definium Therapeutics in?
Definium Therapeutics is in the Healthcare sector and the Drugs industry.
What is Definium Therapeutics' Tenet Score?
Definium Therapeutics' Tenet Score is 50 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




